Tagged with S

Brazil Brazil’s pharma market saw steady growth between 2005 and 2018. Revenues have more than tripled over those 13 years, ending 2018 with over USD 18 billion in revenues.   Made with Visme Presentation Maker   Brazil is gradually climbing the global pharma market rankings and is projected to leap ahead…

Brazil More than half of the top 20 pharma companies in Brazil are domestic, with Ache, EMS Farma, and Eurofarma taking the top three spots. Ranking is based on MAT December 2018.   Made with Visme Infographic Maker

France Researchers at the Institut Pasteur in Paris have become the first in Europe to fully sequence the genome of the 2019-nCoV coronavirus – putting the Institut at the forefront of developing a vaccine for the virus.   As of the 4th February 2020, the Coronavirus 2019-nCoV, originating in the Chinese…

Czech Republic Kieran Leahy, general manager of Takeda in the Czech Republic and Slovakia, recounts how he has led the transformation of Takeda into a specialty care organization at the local level, and his priorities to successfully integrate Shire along this journey. Leahy also breaks down the market access challenges in the…

UAE Genpharm is a Dubai-based regional company providing market access and marketing solutions for rare disease products in the MENA region. Co-Founders Karim Smaira and Kamel Ghammachi provide insights into the rare disease space in the region, explain how the company is positioning itself in the gene therapy arena and why…

Czech Republic Emelie Antoni joined AstraZeneca in Sweden 20 years ago, evolving in global, regional and local roles. Last year, she became country manager for Czech Republic & Slovakia, with an ambitious plan to triple revenues during her tenure. She lays down the pillars of her plan, discusses the evolving role of…

Czech Republic Robin Turner, general manager of Roche Czech Republic, shares how he transformed the affiliate from a “local” company to a highly engaged member of the Roche group whilst breaking down the obstacles to introducing innovative therapies and making personalized medicine a reality in the Czech Republic. Turner sees the increased…

UAE Eli Lilly’s president and general manager for the SAMETA (South Asia, Middle East, Turkey, and Africa) region, José Antonio Alas, discusses the challenges attached to overseeing 70 countries and half of the world’s population, the main opportunities for Lilly’s diabetes and oncology portfolio in the region, and the importance of…

China The Chinese healthcare market has transformed dramatically in the past few years. There have been many reforms centred around the country’s vision of becoming a healthcare technology powerhouse in the next couple of decades and ‘innovation’ has become a buzzword touted by both foreign and local players alike. But in…

Czech Republic Increasing consolidation and digitalization within the Czech pharmacy sector is forcing consumer healthcare firms to rethink their strategies.   Pharmacy Consolidation Within the Central and Eastern European (CEE) region, the pharmaceutical supply chain is relatively fragmented. However, compared to its neighbours, the Czech Republic has undergone a rapid consolidation and…

Generics Arun Narayan is the Chairman of the Value Added Medicines Sector Group at Medicines for Europe, in addition to serving as Head of Global Portfolio Strategy and Head of European Business Operations at Mylan. Narayan introduces compelling reasons why payers in Europe should consider Value Added Medicines, including cost savings…

USA Takeda’s Jessica S. Scott examines the steps already being taken to bring greater patient engagement to drug development and the regulatory decision-making process in the USA; as well as what more needs to be done in this crucial area.   Steps Taken by FDA Under the Food and Drug Administration…